---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294358643.md"
description: "60 Degrees Pharmaceuticals shares are trading higher after the company announced it enrolled the minimum 24 patients needed to trigger an interim analysis in its clinical study of patients hospitalized with severe babesiosis."
datetime: "2026-07-29T20:58:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294358643.md)
  - [en](https://longbridge.com/en/news/294358643.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294358643.md)
---

# 

60 Degrees Pharmaceuticals shares are trading higher after the company announced it enrolled the minimum 24 patients needed to trigger an interim analysis in its clinical study of patients hospitalized with severe babesiosis.

### Related Stocks

- [SXTP.US](https://longbridge.com/en/quote/SXTP.US.md)
- [SXTPW.US](https://longbridge.com/en/quote/SXTPW.US.md)

## Related News & Research

- [60 Degrees Pharma hits minimum enrollment trigger for interim readout in severe babesiosis tafenoquine trial](https://longbridge.com/en/news/294254910.md)
- [60 Degrees Pharmaceuticals issues Series A, Series B warrants exercisable at $1.49 in $1 million private placement](https://longbridge.com/en/news/294876524.md)
- [10:30 ETCancer Diagnostics Market worth $44.92 billion by 2031 - Exclusive Report by MarketsandMarkets™](https://longbridge.com/en/news/296121121.md)
- [Cancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positive](https://longbridge.com/en/news/295970219.md)
- [IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests](https://longbridge.com/en/news/295963001.md)